RPRD1B and neoplasm: Quantitative analysis (n = 10) revealed that pan-cytokeratin-positive (panCK+) tumor cells accounted for approximately 35% of total cells, with CREPT-positive (CREPT+) and CDK9-positive (CDK9+) cells comprising 77% and 40 %, respectively (Figure 5J).